基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
No content for now
Research Interests
Papers共 18 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Hanako Naganawa,Yoshiki Katada,Shunsaku Nakagawa,Keisuke Umemura, Hiroki Ishimura,Moto Kajiwara, Hiroki Endo,Mitsuhiro Sugimoto, Yurie Katsube, Kinuka Kotani, Saki Ohta,Daiki Hira,
Journal of Pharmaceutical Health Care and Sciencesno. 1 (2024): 1-6
Journal of Pharmaceutical Health Care and Sciencesno. 1 (2024): 1-6
Hanako Naganawa,Yoshiki Katada,Shunsaku Nakagawa,Keisuke Umemura, Hiroki Ishimura, Moto Kajiwara,Hiroki Endo, Mitsuhiro Sugimoto, Yurie Katsube, Kinuka Kotani, Saki Ohta,Daiki Hira,
Journal of pharmaceutical health care and sciencesno. 1 (2024): 37-37
Ririka Aihara,Keisuke Umemura,Yoshiki Katada,Shunsaku Nakagawa, Takashi Kobayashi,Etsuro Hatano,Hiroshi Date,Miki Nagao,Tomohiro Terada
Journal of Infection and Chemotherapy (2024)
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapyno. 8 (2024): 741-745
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeonsno. 6 (2024): 944-953
Hanako Naganawa,Yoshiki Katada,Shunsaku Nakagawa,Keisuke Umemura, Hiroki Ishimura,Moto Kajiwara, Hiroki Endo, Mitsuhiro Sugimoto, Yurie Katsube, Kinuka Kotani, Saki Ohta,Daiki Hira,
Journal of Pharmaceutical Health Care and Sciencesno. 1 (2024): 1-6
MOLECULAR PHARMACEUTICSno. 3 (2024): 1204-1213
Journal of Infection and Chemotherapy (2024)
Transplant Infectious Disease (2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn